Back to VANGUARD GROUP INC

CRNX
6 quarters

Position history for VANGUARD GROUP INC's holdings in CRINETICS PHARMACEUTICALS IN

VANGUARD GROUP INC holds 9.1M shares of CRNX (CRINETICS PHARMACEUTICALS IN), worth $425.3M as of 2025-Q4. The position was decreased (-0.4% shares). CRNX represents 0.0% of VANGUARD GROUP INC's portfolio.

Current Value

$425.3M

Current Shares

9.1M

Total Value Change

+$104M

Total Shares Change

+2.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Decreased
9.1M
-0.4%
$425.3M0.0%$47.39
0
2025-Q3
Decreased
9.2M
-0.9%
$381.9M0.0%$43.51
0
2025-Q2
Decreased
9.3M
-0.6%
$266.2M0.0%$29.96
0
2025-Q1
Increased
9.3M
+2.4%
$312.3M0.0%$34.73
32
2024-Q4
Increased
9.1M
+44.6%
$464.7M0.0%$50.67
42
2024-Q3
New
6.3M
-
$321.3M0.0%$50.75
43

Other major holders of CRNX: FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used